TCG Crossover Management, LLC Q4 2025 Filing
Filed February 17, 2026
Portfolio Value
$3.0T
Holdings
43
Report Date
Q4 2025
Filing Type
13F-HR
All Holdings (43 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ABVXABIVAX SA AMERICAN DEPOSITARY SHARES | 7,111,596 | $959.0B | 31.74% | |
| 2 | COGTCOGENT BIOSCIENCES INC | 5,868,162 | $208.4B | 6.90% | |
| 3 | CGONCG ONCOLOGY INC | 3,670,206 | $152.4B | 5.04% | |
| 4 | TNGXTANGO THERAPEUTICS INC | 12,762,094 | $113.1B | 3.74% | |
| 5 | CNTACENTESSA PHARMACEUTICALS PLC | 4,286,480 | $107.2B | 3.55% | |
| 6 | DYNDYNE THERAPEUTICS INC | 4,615,144 | $90.3B | 2.99% | |
| 7 | RAPTRAPT THERAPEUTICS INC | 2,582,408 | $87.5B | 2.89% | |
| 8 | TYRATYRA BIOSCIENCES INC | 2,898,103 | $76.2B | 2.52% | |
| 9 | AMLXAMYLYX PHARMACEUTICALS INC | 6,243,812 | $75.4B | 2.50% | |
| 10 | YB4PSAVARA INC | 12,362,205 | $74.5B | 2.47% | |
| 11 | GLUEMONTE ROSA THERAPEUTICS INC | 4,622,151 | $72.5B | 2.40% | |
| 12 | OCULOCULAR THERAPEUTIX INC | 5,740,231 | $69.7B | 2.31% | |
| 13 | DNTHDIANTHUS THERAPEUTICS INC | 1,676,624 | $69.1B | 2.29% | |
| 14 | EYPTEYEPOINT PHARMACEUTICALS INC | 3,572,335 | $65.3B | 2.16% | |
| 15 | GPCRSTRUCTURE THERAPEUTICS INC | 920,857 | $64.0B | 2.12% | |
| 16 | SYRESPYRE THERAPEUTICS INC | 1,900,582 | $62.3B | 2.06% | |
| 17 | FULCFULCRUM THERAPEUTICS INC | 5,250,000 | $59.4B | 1.97% | |
| 18 | LQDALIQUIDIA TECHNOLOGIES INC | 1,710,084 | $59.0B | 1.95% | |
| 19 | BHVNBIOHAVEN LTD | 4,631,317 | $52.3B | 1.73% | |
| 20 | IMVTIMMUNOVANT INC | 1,660,933 | $42.2B | 1.40% | |
| 21 | KODKODIAK SCIENCES INC | 1,445,538 | $40.4B | 1.34% | |
| 22 | ADCTADC THERAPEUTICS SA | 11,390,175 | $40.2B | 1.33% | |
| 23 | LBRXLB PHARMACEUTICALS INC | 1,745,015 | $38.8B | 1.29% | |
| 24 | XNCRXENCOR INC | 2,452,138 | $37.5B | 1.24% | |
| 25 | RVMDREVOLUTION MEDICINES INC | 436,473 | $34.8B | 1.15% | |
| 26 | AGIOAGIOS PHARMACEUTICALS INC | 1,181,841 | $32.2B | 1.06% | |
| 27 | ARVNARVINAS HOLDING CO LLC | 2,666,216 | $31.6B | 1.05% | |
| 28 | RLAYRELAY THERAPEUTICS INC | 3,220,186 | $27.2B | 0.90% | |
| 29 | JANXJANUX THERAPEUTICS INC | 1,789,617 | $24.7B | 0.82% | |
| 30 | TRDAENTRADA THERAPEUTICS INC | 2,088,392 | $21.5B | 0.71% | |
| 31 | MBXMBX BIOSCIENCES INC | 650,000 | $20.5B | 0.68% | |
| 32 | UPBUPSTREAM BIO INC | 743,886 | $20.2B | 0.67% | |
| 33 | SLNSILENCE THERAPEUTICS PLC | 3,033,560 | $18.4B | 0.61% | |
| 34 | URGNUROGEN PHARMA LTD | 717,347 | $16.8B | 0.56% | |
| 35 | ALECALECTOR INC | 10,000,000 | $15.6B | 0.52% | |
| 36 | MNPRMONOPAR THERAPEUTICS INC | 141,915 | $9.3B | 0.31% | |
| 37 | AVTXAVALO THERAPEUTICS INC | 483,000 | $8.8B | 0.29% | |
| 38 | MAZEMAZE THERAPEUTICS INC | 173,816 | $7.2B | 0.24% | |
| 39 | MIRMMIRUM PHARMACEUTICALS INC | 62,049 | $4.9B | 0.16% | |
| 40 | LONAAthira Pharma, Inc. | 464,398 | $3.3B | 0.11% | |
| 41 | KRROKORRO BIO INC | 416,301 | $3.3B | 0.11% | |
| 42 | VTYXVENTYX BIOSCIENCES INC | 316,195 | $2.9B | 0.09% | |
| 43 | VTGNVISTAGEN THERAPEUTICS INC | 2,676,580 | $1.8B | 0.06% |